{"title":"Prevalence of Dyslipidemia among Women with Polycystic Ovary Syndrome Based on Body Mass Index","authors":"A. A. Mulla","doi":"10.33552/wjgwh.2020.04.000580","DOIUrl":null,"url":null,"abstract":"The purpose of this study was to detect the prevalence of dyslipidemia among polycystic ovary syndrome (PCOS) women with different BMIs. Study design: We conducted a cross-sectional study whereby one hundred and fifteen women diagnosed with PCOS were recruited from a fertility clinic in a 6-month period. All participants had their weight and height measured and body mass index (BMI) calculated. Thereafter, they were divided into two groups: normal BMI (BMI ≤25 kg/m2) and high BMI (BMI >25 kg/m2). Fasting blood samples were obtained and total cholesterol, triglycerides, LDL-C, HDL-C, glucose, and insulin levels were measured in both groups. Insulin resistance was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR) equation. Differences in these variables were assessed using the Chi-square test and Fisher’s exact test. Results: No statistically significant differences were found between both groups of women in terms of total cholesterol, triglycerides, LDL-C, and HDL-C levels. Insulin resistance was significantly more prevalent in the high BMI (78.3%) than in the normal BMI group (59.1%) (P < 0.05). Conclusions: Dyslipidemia in women with PCOS is not related to their BMI. Early detection and treatment of dyslipidemia in this group of women will protect them from cardiovascular diseases.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of gynecology & womens health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/wjgwh.2020.04.000580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The purpose of this study was to detect the prevalence of dyslipidemia among polycystic ovary syndrome (PCOS) women with different BMIs. Study design: We conducted a cross-sectional study whereby one hundred and fifteen women diagnosed with PCOS were recruited from a fertility clinic in a 6-month period. All participants had their weight and height measured and body mass index (BMI) calculated. Thereafter, they were divided into two groups: normal BMI (BMI ≤25 kg/m2) and high BMI (BMI >25 kg/m2). Fasting blood samples were obtained and total cholesterol, triglycerides, LDL-C, HDL-C, glucose, and insulin levels were measured in both groups. Insulin resistance was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR) equation. Differences in these variables were assessed using the Chi-square test and Fisher’s exact test. Results: No statistically significant differences were found between both groups of women in terms of total cholesterol, triglycerides, LDL-C, and HDL-C levels. Insulin resistance was significantly more prevalent in the high BMI (78.3%) than in the normal BMI group (59.1%) (P < 0.05). Conclusions: Dyslipidemia in women with PCOS is not related to their BMI. Early detection and treatment of dyslipidemia in this group of women will protect them from cardiovascular diseases.